Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1573, 2007-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Palivizumab for RSV prevention in high-risk children
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 520, 2007-01 ,pp. :
Access to resources
Recommend
Palivizumab poor performer for prevention of RSV
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 623, 2011-01 ,pp. :
Stroke prevention in the high-risk patient
Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 12, 2007-08 ,pp. :
Palivizumab prophylaxis safe for second RSV season
Inpharma, Vol. 1, Iss. 1376, 2003-01 ,pp. :